![](https://www.diabetesnews.com/wp-content/uploads/2012/04/needles_insulin_1-150x150.jpg)
An investigational compound from Novo Nordisk, significantly reduces the rates of nocturnal hypoglycemia by 25%, compared to insulin glargine.
Read more
An investigational compound from Novo Nordisk, significantly reduces the rates of nocturnal hypoglycemia by 25%, compared to insulin glargine.
Read more